FIGURE 6.
Intracranial response of metastatic lesions in the brain following larotrectinib (200 mg/day) treatment. MRI scans show substantial reductions in lesion sizes following 7 months of treatment. MRI, magnetic resonance imaging
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.